Loading
NASDAQHealthcareMedical - Devices
Latest quote
$4.38
−$0.07 · -1.57%
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Previous close
$4.38
−$0.07 · -1.57%
Regular session · ET · Market data may be delayed.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Day range
Current $4.38
52-week range
Current $4.38
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
67
Undervalued
Sentiment
36
Bearish
Risk
72
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.
Day range
Current $4.38
52-week range
Current $4.38
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 44.05M USD | 32.63M USD | 20.4M USD | 16.74M USD | 13.01M USD |
| Cost of goods sold | 10.08M USD | 8.08M USD | 6.04M USD | 4.33M USD | 4.99M USD |
| Gross profit | 33.97M USD | 24.55M USD | 14.36M USD | 12.41M USD | 8.02M USD |
| Research and development | 1.35M USD | 673K USD | 579K USD | 567K USD | 1.1M USD |
| Selling, general, and administrative | 26.79M USD | 17.67M USD | 13.57M USD | 20.03M USD | 20.28M USD |
| Operating expenses | 29.02M USD | 19.13M USD | 14.9M USD | 21.36M USD | 22.17M USD |
| Interest expense | 6.25M USD | 13.64M USD | 15.62M USD | 14.13M USD | 7.1M USD |
| Depreciation and amortization | 1.28M USD | 1.15M USD | 1.03M USD | 952K USD | 1.24M USD |
| Operating income | 4.95M USD | 5.42M USD | −540K USD | −8.95M USD | −14.14M USD |
| Net income | 11.81M USD | −31.37M USD | −25.81M USD | −10.29M USD | −27.26M USD |
Company facts updated Sep 7, 2026.
Third-party consensus; not a GoAI recommendation.
Average target
$54.00
1132.88% upside| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Oct 18, 2024 | 1:375 | — | — |
Effective Oct 18, 2024
1:375
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWC
Invesco NASDAQ Future Gen 200 ETFQQQSAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
